Page last updated: 2024-11-06

tenilsetam

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tenilsetam is a synthetic, racemic compound that acts as a positive allosteric modulator of the α-7 nicotinic acetylcholine receptor. It is believed to enhance cognitive function by improving communication between neurons. Research suggests that tenilsetam may have potential applications in treating cognitive deficits associated with Alzheimer's disease, age-related cognitive decline, and schizophrenia. It is also being investigated for its potential as a neuroprotective agent.'

tenilsetam: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65649
CHEMBL ID2104853
SCHEMBL ID194668
MeSH IDM0165526

Synonyms (41)

Synonym
86696-86-8
tenilsetam
cas-997
3-thiophen-2-ylpiperazin-2-one
F2147-0982
3-(thiophen-2-yl)piperazin-2-one
EN300-93479
CHEMBL2104853
tenilsetamum
o4q7xm74n6 ,
piperazinone, 3-(2-thienyl)-
unii-o4q7xm74n6
piperazinone, 3-(2-thienyl)-, (+-)-
(+-)-3-(2-thienyl)-2-piperazinone
tenilsetam [inn]
cas 997
tenilsetamum [latin]
2-piperazinone, 3-(2-thienyl)-
85606-97-9
3-thiophen-2-yl-piperazin-2-one
AB07563
AKOS011636381
smr002530465
MLS006010413
AB37813
(r)-3-thiophen-2-yl-piperazin-2-one
(s)-3-thiophen-2-yl-piperazin-2-one
AB37814
SCHEMBL194668
3-(2-thienyl)-piperazin-2-one
BBACKDMGYMXYLE-UHFFFAOYSA-N
3-(2-thienyl)piperazin-2-one
hr 029
pas 997
piperazinone,3-(2-thienyl)-(9ci)
Z978935216
Q27285322
DTXSID701006187
3-(thiophen-2-yl)-3,4,5,6-tetrahydropyrazin-2-ol
CS-0136355
E98662

Research Excerpts

Effects

ExcerptReferenceRelevance
"Tenilsetam has anti-inflammatory effects evidenced by the decreased number of microglia in both the cerebellum and hippocampus, and decreased TNF-α levels in the GFAP-IL6 Tenilsetam fed animals."( Investigation Into the Effects of Tenilsetam on Markers of Neuroinflammation in GFAP-IL6 Mice.
Dhananjayan, K; Gunawardena, D; Gyengesi, E; Liang, H; Millington, C; Münch, G; Niedermayer, G; Sirijovski, D; Sonego, S; Venigalla, M, 2018
)
2.2

Dosage Studied

ExcerptRelevanceReference
" In reference to placebo, the increase of N2-P300 amplitude after the highest dosage of TEN, as well as after CDM, amounted to approximately 5 microV, which confirms the hypothesis that nootropic drugs may influence the P300 amplitude in the sense of an improved availability of cognitive processing resources."( Psychophysiological research in psychiatry and neuropsychopharmacology. II. The investigation of antihypoxidotic/nootropic drugs (tenilsetam and co-dergocrine-mesylate) in elderlies with the Viennese Psychophysiological Test-System (VPTS).
Anderer, P; Presslich, O; Resch, F; Saletu, B; Schuster, P; Semlitsch, HV, 1989
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (9.09)18.7374
1990's6 (54.55)18.2507
2000's3 (27.27)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.04 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (9.09%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]